Congress Park Capital LLC Abb Vie Inc. Transaction History

Congress Park Capital LLC

$269 Million
Q3 2024

A detailed history of Congress Park Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Congress Park Capital LLC holds 3,662 shares of ABBV stock, worth $651,872. This represents 0.27% of its overall portfolio holdings.

Number of Shares

3,662

Previous 3,662 -0.0%

Holding current value

$651,872

Previous $628,000 15.13%

% of portfolio

0.27%

Previous 0.25%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $4,794 - $5,463	-30 Reduced 0.81%	3,662 $666,000
Q4 2023 Jan 19, 2024	SELL	$137.6 - $154.97 $2,752 - $3,099	-20 Reduced 0.54%	3,692 $572,000
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $13,359 - $15,465	-100 Reduced 2.62%	3,712 $553,000
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $132,510 - $164,900	-1,000 Reduced 20.78%	3,812 $513,000
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $10,845 - $12,490	-75 Reduced 1.53%	4,812 $766,000
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $6,915 - $8,293	-50 Reduced 1.01%	4,887 $790,000
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $30,197 - $34,634	225 Added 4.78%	4,937 $663,000
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $4,128 - $5,248	-30 Reduced 0.63%	4,712 $722,000
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $118,781 - $147,375	-900 Reduced 15.95%	4,742 $769,000
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $26,600 - $30,195	-250 Reduced 4.24%	5,642 $609,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $10,521 - $11,721	100 Added 1.73%	5,892 $664,000
Q4 2020 Jan 19, 2021	SELL	$80.49 - $108.67 $40,245 - $54,335	-500 Reduced 7.95%	5,792 $621,000
Q3 2020 Oct 20, 2020	BUY	$85.91 - $100.83 $33,333 - $39,122	388 Added 6.57%	6,292 $551,000
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $58,769 - $78,642	801 Added 15.7%	5,904 $580,000
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $64 - $97	1 Added 0.02%	5,103 $389,000
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $144 - $180	2 Added 0.04%	5,102 $452,000
Q3 2019 Oct 24, 2019	BUY	$62.98 - $75.72 $62 - $75	1 Added 0.02%	5,100 $386,000
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $131 - $167	2 Added 0.04%	5,099 $345,000
Q1 2019 Apr 18, 2019	BUY	$77.14 - $90.79 $77 - $90	1 Added 0.02%	5,097 $411,000
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $77 - $96	1 Added 0.02%	5,096 $470,000
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $88 - $98	1 Added 0.02%	5,095 $482,000
Q2 2018 Aug 06, 2018	BUY	$89.78 - $106.23 $89 - $106	1 Added 0.02%	5,094 $472,000
Q1 2018 Apr 17, 2018	BUY	$92.01 - $123.21 $27,695 - $37,086	301 Added 6.28%	5,093 $482,000
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $429,171 - $470,622	4,792	4,792 $463,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Park Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Congress Park Capital LLC with notifications on news.

Account

Congress Park Capital LLC Abb Vie Inc. Transaction History